BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee DH, Lee MW, Kim PN, Lee YJ, Park HS, Lee JM. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial. Radiology 2021;:210309. [PMID: 34313474 DOI: 10.1148/radiol.2021210309] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Park S, Kim JH, Yoon JH, Lee JM. Comparison of Ablation Performance between Octopus Multipurpose Electrode and Conventional Octopus Electrode. Korean J Radiol 2023;24. [DOI: 10.3348/kjr.2022.0600] [Reference Citation Analysis]
2 Jo MG, Lee MW, Ahn S, Kang TW, Song KD, Cha DI, Min JH, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events. Ultrasonography 2023;42:41-53. [PMID: 36353791 DOI: 10.14366/usg.22041] [Reference Citation Analysis]
3 Lee MW, Lee JM, Koh YH, Chung JW. 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Local Ablation Therapy of Hepatocellular Carcinoma: What's New? Korean J Radiol 2023;24:10-4. [PMID: 36606614 DOI: 10.3348/kjr.2022.0555] [Reference Citation Analysis]
4 Du F, Zhang L, Zhang Y, Fan H, Ren L. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis. Clin Res Hepatol Gastroenterol 2023;47:102069. [PMID: 36513251 DOI: 10.1016/j.clinre.2022.102069] [Reference Citation Analysis]
5 Yan H, Xiang Z, Zhao C, Zou S, Huang M. Long-term Outcomes of Patients with Hepatocellular Carcinoma Who Underwent Microwave Ablation after Downstaging with Transarterial Chemoembolization to Barcelona Clinic Liver Cancer Stage A. J Vasc Interv Radiol 2022:S1051-0443(22)01893-0. [PMID: 36581194 DOI: 10.1016/j.jvir.2022.12.466] [Reference Citation Analysis]
6 Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean J Radiol 2022;23:1126-240. [PMID: 36447411 DOI: 10.3348/kjr.2022.0822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wu G, Li J, Li C, Ou X, Feng K, Xia F, Chen Z, Zhang L, Ma K. Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study. Cancer Medicine 2022. [DOI: 10.1002/cam4.5428] [Reference Citation Analysis]
8 Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clin Mol Hepatol 2022;28:583-705. [PMID: 36263666 DOI: 10.3350/cmh.2022.0294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Garcia-Monaco RD, Chung JW, Vilgrain V, Bouattour M, Covey AM. Summary of key guidelines for locoregional treatment of HCC in Asia, Europe, South and North America. Br J Radiol 2022;95:20220179. [PMID: 35848758 DOI: 10.1259/bjr.20220179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Deng Q, He M, Fu C, Feng K, Ma K, Zhang L. Radiofrequency ablation in the treatment of hepatocellular carcinoma. Int J Hyperthermia 2022;39:1052-63. [PMID: 35944905 DOI: 10.1080/02656736.2022.2059581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tang N, Zhu J, Zeng Y, Zhang X, Zhou J, Hashmi MF. Multiradiographic Diagnosis of Primary Hepatocellular Carcinoma and Evaluation of Its Postoperative Observation after Interventional Treatment. Contrast Media & Molecular Imaging 2022;2022:1-7. [DOI: 10.1155/2022/5292200] [Reference Citation Analysis]
12 Kim TH, Lee JM, Lee DH, Joo I, Park SJ, Yoon JH. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis. Eur Radiol 2022. [PMID: 35907024 DOI: 10.1007/s00330-022-08991-1] [Reference Citation Analysis]
13 . ABDOMEN/BECKEN – No-Touch-Radiofrequenzablation überzeugt bei kleinen hepatozellulären Karzinomen. Rofo 2022;194:598-601. [DOI: 10.1055/a-1692-1374] [Reference Citation Analysis]
14 Duan L, Zhang BH, Zheng XH. No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma. Radiology 2022;:211994. [PMID: 35230184 DOI: 10.1148/radiol.211994] [Reference Citation Analysis]
15 Tan Y, Wang X, Ma K, Zhang L, Li J, Chen P, Zhang B. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study. Int J Hyperthermia 2022;39:190-9. [PMID: 35042449 DOI: 10.1080/02656736.2021.2024279] [Reference Citation Analysis]
16 Zou XZ, Hao JF, Zhou XH. Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation. Front Oncol 2021;11:796152. [PMID: 34900747 DOI: 10.3389/fonc.2021.796152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lee DH. Recent technical advances in radiofrequency ablations for hepatocellular carcinoma. Int J Gastrointest Interv 2021;10:169-74. [DOI: 10.18528/ijgii210050] [Reference Citation Analysis]